SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Assets, Fair Value Disclosure
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Assets, Fair Value Disclosure of $1.64 million as of 2024-06-30, per its 10-Q filed 2024-09-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2025-02-26
- 2024-06-30: Assets, Fair Value Disclosure $1.64M.
- 2024-03-31: Assets, Fair Value Disclosure $2.79M.
- 2023-12-31: Assets, Fair Value Disclosure $2.89M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2024-06-30 | $1.64M 10-Q · filed 2024-09-04 |
| 2024-03-31 | $2.79M 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $2.89M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |